CVE detail

CVE-2023-42666 — CVE-2023-42666

Published 2023-10-19 · Modified 2026-06-17 · Vendor dexma · Product dexgate · Source nvd

MEDIUM

severity

CVSS-derived band

5.3

CVSS v3

0–10 scale

0.0038

EPSS probability

exploitation probability, 30d

31.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.